Allspring Global Investments
ARCT icon

Allspring Global Investments’s Arcturus Therapeutics ARCT Stock Holding History

Allspring Global Investments’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Buy
27,651
+781
+3% +$6.16K ﹤0.01% 1671
2026
Q1 		$211K Buy
+26,870
New +$196K ﹤0.01% 1598
2024
Q3 		– Sell
-7,820
Closed -$190K – 2454
2024
Q2 		$190K Sell
7,820
-21,737
-74% -$659K ﹤0.01% 1718
2024
Q1 		$998K Sell
29,557
-85,253
-74% -$3.02M ﹤0.01% 1364
2023
Q4 		$3.62M Buy
114,810
+79,387
+224% +$1.89M 0.01% 1031
2023
Q3 		$905K Sell
35,423
-7,159
-17% -$221K ﹤0.01% 1384
2023
Q2 		$1.22M Buy
42,582
+37,796
+790% +$1.03M ﹤0.01% 1358
2023
Q1 		$115K Buy
4,786
+2,961
+162% +$53.1K ﹤0.01% 2002
2022
Q4 		$31K Buy
1,825
+673
+58% +$11.7K ﹤0.01% 2474
2022
Q3 		$17K Buy
+1,152
New +$19.3K ﹤0.01% 2644
2022
Q2 		– Sell
-838
Closed -$22K – 2693
2022
Q1 		$22K Sell
838
-47
-5% -$1.2K ﹤0.01% 2932
2021
Q4 		$32K Buy
+885
New +$36.1K ﹤0.01% 2878

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Allspring Global Investments's ARCT Position: Q2 2026 in Review

Allspring Global Investments increased its Arcturus Therapeutics (ARCT) stake by 2.9% in Q2 2026, buying an estimated $6.16K and bringing the position to 27,651 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

Allspring Global Investments first reported a position in ARCT in Q4 2021 and has held it in 12 quarters since. The position peaked at $3.62M in Q4 2023. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Allspring Global Investments held 27,651 shares of Arcturus Therapeutics worth $186K as of Q2 2026.
  • Allspring Global Investments bought 781 Arcturus Therapeutics shares in Q2 2026, an estimated $6.16K.
  • Arcturus Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1671 holding.
  • Allspring Global Investments first reported a position in Arcturus Therapeutics in Q4 2021 and has held it in 12 quarters since.
  • Allspring Global Investments's Arcturus Therapeutics position peaked at $3.62M in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.